Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06455566

Vascular Access for Minimally-invasive Leadless Pacemaker Implantation Through the Right Jugular routE

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Leadless pacemakers (LP) are associated with a lower risk of revision compared with transvenous pacemakers. However, LPs implantation is associated with a 0.6% risk of complication at the femoral vein puncture site (e.g. arteriovenous fistula, haemorrhage, pseudoaneurysm, etc.). As a consequence, the need for prolonged in-hospital monitoring after LP implantation though the right femoral (RF)vein is a barrier to same-day discharge. Recently, right internal jugular (RIJ) vein access has emerged an alternative to right RF vein access for LP implantation (with a regulatory approval for MEDTRONIC Micra LP). The aims of this registry are the following : * evaluate the feasibility of RIJ access for LP implantation; * confirm the acute and chronic safety of RIJ access for LP implantation; * compare RIJ to RF (historical cohort) vein access regarding procedural characteristics and outcomes; * evaluate the feasibility of same-day discharge avec LP implantation through the RIJ vein.

Conditions

Interventions

TypeNameDescription
DEVICELeadless pacemaker implantation through right internal jugular veinLeadless pacemaker implantation through right internal jugular vein

Timeline

Start date
2024-05-01
Primary completion
2026-05-01
Completion
2027-05-01
First posted
2024-06-12
Last updated
2025-03-26

Locations

13 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06455566. Inclusion in this directory is not an endorsement.